Recurrent toxin-mediated perineal erythema: Eleven pediatric cases

Archives of Dermatology

Volumn 144, Issue 2, 2008, Pages 239-243

  Patrizi, Annalisa ^a,b   Raone, Beatrice ^a   Savoia, Francesco ^a   Ricci, Giampaolo ^a   Neri, Iria ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Clinica Dermatologica   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID;

ARTICLE; BACTERIUM CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DESQUAMATION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; ERYTHEMA; FEMALE; HUMAN; IMPETIGO; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PERINEUM; PHYSICAL EXAMINATION; PRESCHOOL CHILD; PRIORITY JOURNAL; STAPHYLOCOCCUS; STREPTOCOCCUS;

ANTI-BACTERIAL AGENTS; BACTERIAL TOXINS; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; ERYTHEMA; FEMALE; HUMANS; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PERINEUM; RECURRENCE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS; SUPERANTIGENS;

EID: 39649096950     PISSN: 0003987X     EISSN: 0003987X     Source Type: Journal    
DOI: 10.1001/archdermatol.2007.47     Document Type: Article

References (16)

1. Efstratiou A. Group A streptococci in the 1990s. J Antimicrob Chemother. 2000;45(suppl):3-12.
2. Floret D. Clinical aspects of streptococcal and staphylococcal toxinic diseases. Arch Pediatr. 2001;8(suppl 4):762s-768s.
3. Manders SM. Toxin-mediated streptococcal and staphylococcal disease. J Am Acad Dermatol. 1998;39(3):383-398.
4. Alouf JE, Muller-Alouf H. Staphylococcal and streptococcal superantigens: molecular, biological and clinical aspects. Int J Med Microbiol. 2003;292(7-8):429-440.
5. Llewelyn M, Cohen J. Superantigens: microbial agents that corrupt immunity. Lancet Infect Dis. 2002;2(3):156-162.
6. Manders SM, Heymann WR, Atillasoy E, Kleeman J, Schlievert PM. Recurrent toxin-mediated perineal erythema. Arch Dermatol. 1996;132(1):57-60.
7. Friter BS, Lucky AW. The perineal eruption of Kawasaki syndrome. Arch Dermatol. 1988;124(12):1805-1810.
8. Newburger JW, Fulton DR. Kawasaki disease. Curr Opin Pediatr. 2004;16(5):508-514.
9. Fulton DR, Newburger JW. Long-term cardiac sequelae of Kawasaki disease. Curr Rheumatol Rep. 2000;2(4):324-329.
10. Iemura M, Ishii M, Sugimura T, Akagi T, Kato H. Long term consequences of regressed coronary aneurysms after Kawasaki disease: vascular wall morphology and function. Heart. 2000;83(3):307-311.
11. Leung DY, Meissner HC, Fulton DR, Murray DL, Kotzin BL, Schlievert PM. Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome. Lancet. 1993;342(8884):1385-1388.
12. Leung DYM, Meissner HC, Shulman ST, et al. Prevalence of superantigen-secreting bacteria in patients with Kawasaki disease. J Pediatr. 2002;140(6):742-746.
13. Avner JR, Shaw KN, Chin AJ. Atypical presentation of Kawasaki disease with early development of giant coronary artery aneurysms. J Pediatr. 1989;114(4, pt 1):605-606.
14. Schuh S, Laxer RM, Smalhorn JF, Hilliard RI, Rowe RD. Kawasaki disease with atypical presentation. Pediatr Infect Dis J. 1988;7(3):201-203.
15. Ammerman SD, Rao MS, Shope TC, Ragsdale CG. Diagnostic uncertainty in atypical Kawasaki disease, and a new finding: exudative conjunctivitis. Pediatr Infect Dis. 1985;4(2):210-211.
16. Vélez A, Moreno JC. Febrile perianal streptococcal dermatitis. Pediatr Dermatol. 1999;16(1):23-24.